关注
Dr. Murali Munisamy
Dr. Murali Munisamy
Associate Professor , Department of Translational Medicine, AIIMS Bhopal.
在 aiimsbhopal.edu.in 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Allelic hierarchy of CDH23 mutations causing non-syndromic deafness DFNB12 or Usher syndrome USH1D in compound heterozygotes
JM Schultz, R Bhatti, AC Madeo, A Turriff, JA Muskett, CK Zalewski, ...
Journal of medical genetics 48 (11), 767-775, 2011
1192011
Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians
A Biswas, R Ranjan, A Meena, MS Akhter, BK Yadav, M Munisamy, ...
Journal of Stroke and Cerebrovascular Diseases 18 (2), 103-110, 2009
1142009
Role of MTHFR C677T polymorphism in ischemic stroke
I Panigrahi, T Chatterjee, A Biswas, M Behari, PV Choudhry, R Saxena
Neurology India 54 (1), 48-50, 2006
692006
Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity
RS Jabir, R Naidu, MABA Annuar, GF Ho, M Munisamy, J Stanslas
Pharmacogenomics 13 (16), 1979-1988, 2012
562012
Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactions
M Munisamy, N Mukherjee, L Thomas, AT Pham, A Shakeri, Y Zhao, ...
American Journal of Cancer Research 11 (12), 5762, 2021
372021
Histone demethylase KDM5B as a therapeutic target for cancer therapy
A Jose, GG Shenoy, G Sunil Rodrigues, NAN Kumar, M Munisamy, ...
Cancers 12 (8), 2121, 2020
362020
Procalcitonin as a predictive marker in COVID-19: A systematic review and meta-analysis
A Kumar, E Karn, K Trivedi, P Kumar, G Chauhan, A Kumari, P Pant, ...
PloS one 17 (9), e0272840, 2022
352022
The effect of uridine diphosphate glucuronosyltransferase (UGT) 1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic …
M Munisamy, M Tripathi, M Behari, S Raghavan, DC Jain, B Ramanujam, ...
Molecular diagnosis & therapy 17, 319-326, 2013
342013
Pharmacogenomics and personalized medicine in type 2 diabetes mellitus: potential implications for clinical practice
P Venkatachalapathy, S Padhilahouse, M Sellappan, T Subramanian, ...
Pharmacogenomics and Personalized Medicine, 1441-1455, 2021
272021
Pharmacogenetics of CYP2C19 genetic polymorphism on clopidogrel response in patients with ischemic stroke from Saudi Arabia
AA Alhazzani, M Munisamy, G Karunakaran
Neurosciences Journal 22 (1), 31-37, 2017
272017
Liquid biopsy approaches for pleural effusion in lung cancer patients
G Baburaj, RR Damerla, KS Udupa, P Parida, M Munisamy, J Kolesar, ...
Molecular biology reports 47 (10), 8179-8187, 2020
252020
Vitamin D supplementation in diabetic foot ulcers: a current perspective
SJ Kurian, SS Miraj, R Benson, M Munisamy, K Saravu, GS Rodrigues, ...
Current Diabetes Reviews 17 (4), 512-521, 2021
242021
Impact of MTHFR (C677T) gene polymorphism on antiepileptic drug monotherapy in North Indian epileptic population
M Munisamy, M Al-Gahtany, M Tripathi, V Subbiah
Annals of Saudi medicine 35 (1), 51-57, 2015
182015
Biomarkers for antiplatelet therapies in acute ischemic stroke: a clinical review
A Alhazzani, P Venkatachalapathy, S Padhilahouse, M Sellappan, ...
Frontiers in Neurology 12, 667234, 2021
132021
Cannabinoids as an alternative option for conventional analgesics in cancer pain management: a pharmacogenomics perspective
A Jose, L Thomas, G Baburaj, M Munisamy, M Rao
Indian journal of palliative care 26 (1), 129, 2020
132020
Development of pH-dependent chronomodulated delivery systems of 5-fluorouracil and oxaliplatin to treat colon cancer
JG BH, SJ Shankar, M Munisamy, A RS, VS Sagar
Int J App Pharm 12 (5), 118-130, 2020
112020
The association between micronutrient levels and diabetic foot ulcer: A systematic review with meta-analysis
SJ Kurian, T Baral, MK Unnikrishnan, R Benson, M Munisamy, K Saravu, ...
Frontiers in Endocrinology 14, 1152854, 2023
102023
Pharmacogenetics of CYP3A5 on Carbamazepine pharmacokinetics in epileptic patients developing toxicity
M Al-Gahtany, G Karunakaran, M Munisamy
BMC Genomics 15 (Suppl 2), P2, 2014
92014
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review
R Benson, MK Unnikrishnan, SJ Kurian, SU Velladath, GS Rodrigues, ...
Expert Review of Anti-infective Therapy 21 (1), 15-27, 2023
82023
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational …
L Thomas, SR Birangal, R Ray, S Sekhar Miraj, M Munisamy, M Varma, ...
Therapeutic Advances in Drug Safety 12, 20420986211041277, 2021
82021
系统目前无法执行此操作,请稍后再试。
文章 1–20